Literature DB >> 28560690

Extrarenal determinants of kidney filter function.

Eunsil Hahm1, Vasil Peev2,3, Jochen Reiser1.   

Abstract

The kidney is an organ involved in cross talk with many human organs. The link between the immune system and the kidney has been studied in some detail, although data precisely elucidating their interaction are sparse, in particular with regard to the function of the kidney filter apparatus. Current research suggests that an understanding of the impairment of this cross talk between the bone marrow, as a fundament of the immune system and the kidney will provide meaningful insights into the pathophysiological mechanisms of impaired kidney filter function. Circulating factors have long been implicated in the pathogenesis of idiopathic nephrotic syndrome, particularly focal segmental glomerulosclerosis (FSGS) and its recurrence. Soluble urokinase receptor (suPAR) has emerged as a circulating factor responsible for FSGS and also as an early predictive marker for the development of various renal diseases. The bone marrow has recently been revealed as a predominant source of suPAR with deleterious effects on the kidney filter. These new findings have led to bone marrow or hematopoietic stem cell transplants being considered as potential therapeutic options for preventing the post-transplantation recurrence of FSGS or even as a treatment for the original disease associated with high suPAR levels. Whereas bone marrow transplantation for patients with pre-existing chronic kidney disease is challenging, recent clinical trials have demonstrated the promising outcome of combined bone marrow and kidney transplantation in patients with kidney failure. In this review, with its brief update on suPAR, we describe the critical new role of the bone marrow in the pathogenesis of the kidney disease process and the functional connection between these two organs through the soluble mediator, suPAR. We also comment on the feasibility of bone marrow transplants for the treatment of patients with chronic renal failure arising from recurrent FSGS.

Entities:  

Keywords:  Bone marrow; Chronic kidney disease; FSGS recurrence; Nephrotic syndrome; suPAR

Mesh:

Substances:

Year:  2017        PMID: 28560690      PMCID: PMC6133290          DOI: 10.1007/s00441-017-2635-7

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  57 in total

1.  Recurrent focal segmental glomerulosclerosis after renal transplantation: is early recurrent proteinuria always a surrogate marker for recurrence of the disease?

Authors:  S Kaplan-Pavlovcic; D Ferluga; A Hvala; N Chwatal-Lakic; A F Bren; A Vizjak
Journal:  Transplant Proc       Date:  2002-12       Impact factor: 1.066

2.  Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients.

Authors:  R Y Gohh; A F Yango; P E Morrissey; A P Monaco; A Gautam; M Sharma; E T McCarthy; V J Savin
Journal:  Am J Transplant       Date:  2005-12       Impact factor: 8.086

Review 3.  Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.

Authors:  Ellen T McCarthy; Mukut Sharma; Virginia J Savin
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-21       Impact factor: 8.237

4.  "The FSGS factor:" enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma.

Authors:  M Sharma; R Sharma; E T McCarthy; V J Savin
Journal:  J Am Soc Nephrol       Date:  1999-03       Impact factor: 10.121

Review 5.  Chronic kidney disease after hematopoietic cell transplantation: a systematic review.

Authors:  M J Ellis; C R Parikh; J K Inrig; M Kanbay; M Kambay; U D Patel
Journal:  Am J Transplant       Date:  2008-11       Impact factor: 8.086

6.  A humanized mouse model of idiopathic nephrotic syndrome suggests a pathogenic role for immature cells.

Authors:  Anne-Laure Sellier-Leclerc; Arnaud Duval; Stéphanie Riveron; Marie-Alice Macher; Georges Deschenes; Chantal Loirat; Marie-Christine Verpont; Michel Peuchmaur; Pierre Ronco; Renato C Monteiro; Elie Haddad
Journal:  J Am Soc Nephrol       Date:  2007-09-12       Impact factor: 10.121

7.  HLA-mismatched renal transplantation without maintenance immunosuppression.

Authors:  Tatsuo Kawai; A Benedict Cosimi; Thomas R Spitzer; Nina Tolkoff-Rubin; Manikkam Suthanthiran; Susan L Saidman; Juanita Shaffer; Frederic I Preffer; Ruchuang Ding; Vijay Sharma; Jay A Fishman; Bimalangshu Dey; Dicken S C Ko; Martin Hertl; Nelson B Goes; Waichi Wong; Winfred W Williams; Robert B Colvin; Megan Sykes; David H Sachs
Journal:  N Engl J Med       Date:  2008-01-24       Impact factor: 91.245

8.  Tolerance and chimerism after renal and hematopoietic-cell transplantation.

Authors:  John D Scandling; Stephan Busque; Sussan Dejbakhsh-Jones; Claudia Benike; Maria T Millan; Judith A Shizuru; Richard T Hoppe; Robert Lowsky; Edgar G Engleman; Samuel Strober
Journal:  N Engl J Med       Date:  2008-01-24       Impact factor: 91.245

9.  A retrospective study of focal segmental glomerulosclerosis: clinical criteria can identify patients at high risk for recurrent disease after first renal transplantation.

Authors:  Rutger J H Maas; Jeroen K J Deegens; Jan A J G van den Brand; Elisabeth A M Cornelissen; Jack F M Wetzels
Journal:  BMC Nephrol       Date:  2013-02-22       Impact factor: 2.388

10.  Full-length soluble urokinase plasminogen activator receptor down-modulates nephrin expression in podocytes.

Authors:  Massimo Alfano; Paola Cinque; Guido Giusti; Silvia Proietti; Manuela Nebuloni; Silvio Danese; Silvia D'Alessio; Marco Genua; Federica Portale; Manuela Lo Porto; Pravin C Singhal; Maria Pia Rastaldi; Moin A Saleem; Domenico Mavilio; Joanna Mikulak
Journal:  Sci Rep       Date:  2015-09-18       Impact factor: 4.379

View more
  1 in total

1.  Diagnostic and Prognostic Value of Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) in Focal Segmental Glomerulosclerosis and Impact of Detection Method.

Authors:  Wolfgang Winnicki; Gere Sunder-Plassmann; Gürkan Sengölge; Ammon Handisurya; Harald Herkner; Christoph Kornauth; Bernhard Bielesz; Ludwig Wagner; Željko Kikić; Sahra Pajenda; Thomas Reiter; Benjamin Schairer; Alice Schmidt
Journal:  Sci Rep       Date:  2019-09-24       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.